1 Min Read
May 8 (Reuters) - Novartis Bioventures Ltd:
* Novartis Bioventures Ltd reports 11.1 percent passive stake in Altimmune Inc as of May 4 - SEC filing Source text: (bit.ly/2pXTPB3) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.